Nature27d
Certolizumab pegol
In April 2008, certolizumab pegol (Cimzia; UCB), a tumour-necrosis factor blocker, was approved by the US FDA for the treatment of adult patients with moderate-to-severe Crohn's disease who have ...
Pharmabiz6d
Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy
If approved, avacincaptad pegol has the potential to be the first and only treatment to slow disease progression for eligible patients in Japan. As such, we are committed to working with regulatory ...
Medscape13y
Certolizumab Pegol in Rheumatoid Arthritis
Thus there has been the development of a number of other biologic agents for use in RA including the new TNFi agents: certolizumab pegol (CZP) and golimumab. Experience [5] and randomized ...